Effect of cerium lanthanide on Hela and MCF-7 cancer cell growth in the presence of transferrin

Research in Pharmaceutical Sciences

Volumn 5, Issue 2, 2010, Pages 119-125

  Palizban, A Abbasali ^a   Sadeghi aliabadi, H ^a   Abdollahpour, F ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cerium; Cytotoxicity; Hela cell line; Mcf 7 cell line; MTT assay; Transferrin

Indexed keywords

APOTRANSFERRIN; CERIUM; TRANSFERRIN RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG POTENTIATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMIDITY;

EID: 79953213652     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Slater TF, Sawyer B, Sträuli U. Studies on succinate-tetrazolium reductase systems: III. Points of coupling of four different tetrazolium salts III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta. 1963;77:383-393.
2. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63. (Pubitemid 14203433)
3. Sigel A, Sigel H. Metal ions in biological systems: the lanthanides and their interrelations with biosystems. Vol. 40. New York: Marcel Dekker Inc, 2003.
4. Barron H. Bathsheba's Breast: women, cancer, and history. Bulletin of the history of medicine. 2003;77;727-729.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70. (Pubitemid 30046295)
6. Wang K, Li RC, Cheng Y, Zhu B. Lanthanides- the future drugs? Coord Chem Rev. 1999;190:297-308.
7. Jakupec MA, Unfried P, Keppler BK. Pharmacological properties of cerium compounds. Rev Physiol Biochem Pharmacol. 2005;153:101-111. (Pubitemid 44404355)
8. Fidler IJ. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nature Rev Cancer. 2002;3:453-458.
9. Girones N, Alvarez E, Seth A, Lin IM, Latour DA, Davis RJ. Mutational analysis of the cytoplasmic tail of the human transferrin receptor. Identification of a sub-domain that is required for rapid endocytosis. J Biol Chem. 1991; 266:19006-19012. (Pubitemid 21908183)
10. Paterson S, Armstrong NJ, Iacopetta BJ, McArdle HJ, Morgan EH. Intravesicular pH and iron uptake by immature erythroid cells. J Cell Physiol. 1984;120:225-232. (Pubitemid 14096008)
11. Low H, Grebing C, Lindgren A, Tally M, Sun IL, Crane FL. Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system. J Bioenerg Biomembr. 1987;19:535-540.
12. Chuthapisith S, Layfield R, Kerr ID, Hughes C, Eremin O. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int J Oncol. 2007;30:1545-1551.
13. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695-710.
14. Xiao B, Ji Y, Cui M. Effects of lanthanum and cerium on malignant proliferation and expression of tumor-related gene. Zhonghua Yu Fang Yi Xue Za Zhi. 1997;31:228-230.
15. Mizgerd JP, Molina RM, Stearns RC, Brain JD, Warner AE. Gadolinium induces macrophage apoptosis. J Leuko Biol. 1996;59:189-195. (Pubitemid 26098704)
16. Luk KC. Study of the nature of the metal-binding sites and estimate of the distance between the metal-binding sites in transferrin using trivalent lanthanide ions as fluorescent probes. Biochem. 1971;10:2838-2843.
17. Baker HM, Baker CJ, Smith CA, Baker EN. Metal substitution in transferrins: specific binding of cerium (IV) revealed by the crystal structure of cerium-substituted human lactoferrin. J Biol Inorg Chem. 2000;5:692-698
18. Aisen, P. Transferrin, the transferrin receptor, and the uptake of iron by cells. Metal Ions Biol Syst. 1998;35:585-631.
19. Gatter KC, Brown G, Trowbridge IS, Woolston R, Mason DY .Transferrin receptors in human tissues: Their distribution and possible clinical relevance. J Clin Pathol. 1983;36:539-545. (Pubitemid 13089724)
20. Huebers HA, Finch CA The physiology of transferrin and transferrin receptors. Physiol Rev. 1987;67:520-82.
21. Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today. 2005;10:267-273. (Pubitemid 40222220)
22. Vandewalle B, Granier AM, Peyrat JP, Bonneterre J, Lefebvre J. Transferrin receptors in cultured breast cancer cells. J Cancer Res Clin Oncol. 1985;110:71-76. (Pubitemid 15030766)
23. Park S, Yoon SS, Kim KE, Lee HR, Hur DY, Song H, et al. Interleukin-18 induces transferrin expression in breast cancer cell line MCF-7. Cancer Letters. 2009;286:189-195.
24. Flulk WP, His BL, Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet.1980;2:390-392. (Pubitemid 10056531)
25. Palizban AA, Sadeghi-aliabadi H, Abdollahpour F. Cytotoxic activity of cerium induced by transferrn in Hela cancer cells. 11th Congress of the Asian Pacific Congress of Clinical Biochemistry. Chin Med J. 2008.
26. Palizban AA, Sadeghi-aliabadi H, Abdollahpour F. Anti-cancer activity of the elements of lanthanides group. Arch Iranian Med. 2007.10:4(S1).
27. Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev. 1987;67:520-582. (Pubitemid 17063609)
28. Inoue T, Cavanaugh PG, Steck PA, Brunner N, Nicolson GL. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol. 1993;156:212-217. (Pubitemid 23211281)
29. Ji YJ, Xiao B, Wang ZH, Cui MZ, Lu YY. The suppression effect of light rare earth elements on proliferation of two cancer cell lines. Biomed Envi Sci. 2000;13:287-292.